Medical Xpress September 4, 2024
Despite decades of advancement in treatment, cancer spreading to multiple parts of the body remains one of the biggest challenges facing patients and their health-care teams.
This is particularly true for osteosarcoma, the most common bone cancer in children and teenagers. While survival rates are approximately 70% for people with localized disease, there is a high risk of metastatic spread to the lungs, after which the odds of survival fall dramatically to 20% or less.
Now, scientists at the University of British Columbia have identified a potential drug that could halt osteosarcoma’s spread. In a study published in Clinical Cancer Research, the researchers demonstrate that the compound can reduce lung metastasis in mice by over 90%, while also shrinking the...
Today's Sponsors
Today's Sponsor